Protalix BioTherapeutics
PLX
#8915
Rank
HK$1.08 B
Marketcap
HK$13.46
Share price
-1.14%
Change (1 day)
6.14%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -HK$0.31

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -HK$0.31. In 2024 the company made an earnings per share (EPS) of HK$0.31 a decrease over its 2023 EPS that were of HK$0.93.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$0.31-200.32%
2024HK$0.31-66.67%
2023HK$0.93-138.71%
2022-HK$2.41-50%
2021-HK$4.82181.82%
2020-HK$1.71-82.11%
2019-HK$9.57-31.67%
2018-HK$14.01-72.31%
2017-HK$50.58124.14%
2016-HK$22.57-147.54%
2015HK$47.47-290.63%
2014-HK$24.906.67%
2013-HK$23.35130.77%
2012-HK$10.12-69.77%
2011-HK$33.4619.44%
2010-HK$28.01-12.2%
2009-HK$31.9136.67%
2008-HK$23.35-37.5%
2007-HK$37.3550%
2006-HK$24.903.23%
2005-HK$24.12138.46%
2004-HK$10.12-74%
2003-HK$38.91-0%
2002-HK$38.91-50%
2001-HK$77.82233.33%
2000-HK$23.35-84.21%
1999-HK$147.85-24%
1998-HK$194.54-600%
1997HK$38.91-16.67%
1996HK$46.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-HK$0.86 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$33.54-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel